Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease.
Treatment with 4-aminopyridine improves upper limb tremor of a patient with multiple sclerosis: a video case report.
Glatiramer acetate does not protect from acute ischemic stroke in mice.
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS.
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Laquinimod for multiple sclerosis.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
The NF-κB regulator MALT1 determines the encephalitogenic potential of Th17 cells.
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
Phase 2 BOLD extension study efficacy results for siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis.
Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
Saccadic intrusions: review and update.
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
Multiparametric MRI correlates of sensorimotor function in the spinal cord in multiple sclerosis.
Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain.
Sanofi withdraws Campath in US and EU
GeNeuro and Servier sign partnership to develop first medicine addressing a causal factor of multiple sclerosis
SIRT1 deacetylates RORγt and enhances Th17 cell generation.
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
Potassium-Retaining Diuretics: Amiloride
Clinical and MRI characterization of MS patients with a pure and severe cognitive onset.
Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis

Pages